Cortisol stimulation by recombinant interferon-α2

Joe Roosth, Richard B. Pollard, S. Lori Brown, Walter J. Meyer

Research output: Contribution to journalArticle

71 Scopus citations


Serum cortisol concentrations were determined by radioimmunoassay in cancer patients undergoing experimental therapy with recombinant interferon-α2. Cortisol concentration rose steadily after interferon administration and was significantly different from that on control day at 8 h following intramuscular injection of interferon-α2. Cortisol elevation was increased as weekly doses of interferon were increased (0-120 × 106 units). Recent clinical trials of interferons for treatment of neurological and malignant diseases provide a compelling need to understand the actions and side effects of exogenously administered interferons.

Original languageEnglish (US)
Pages (from-to)311-316
Number of pages6
JournalJournal of Neuroimmunology
Issue number4
StatePublished - Oct 1986


  • Cortisol stimulation
  • Interferon-α
  • Serum
  • Tumor
  • recombinant

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Cortisol stimulation by recombinant interferon-α<sub>2</sub>'. Together they form a unique fingerprint.

  • Cite this

    Roosth, J., Pollard, R. B., Brown, S. L., & Meyer, W. J. (1986). Cortisol stimulation by recombinant interferon-α2. Journal of Neuroimmunology, 12(4), 311-316.